Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01340755 · ClinicalTrials.gov registry record · NA
Laparoscopy-Assisted Transanal Endoscopy Rectosigmoid Resection for Rectal Cancer
A NA study, sponsored by Massachusetts General Hospital.
- Completed
- Registry status
- NA
- Development phase
- 5
- Enrollment target
NCT01340755: Completed NA study, sponsored by Massachusetts General Hospital.
NCT01340755 is a NA study that has completed, run by Massachusetts General Hospital. The registered enrollment target is 5 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01340755, a NA study, has completed, sponsored by Massachusetts General Hospital.
- COMPLETED
- Registry status
- NA
- Development phase
- 5 participants
- Enrollment target
Study Summary
Transanal Endoscopic Rectosigmoid Resection with Laparoscopic Assistance was developed at Massachusetts General Hospital and performed successfully to remove cancer of the lower rectum. Based on the outcomes, the research doctors believe that this investigational surgery may be as safe and effective as standard laparoscopic or open surgery performed to remove rectal cancer, may facilitate the operation and reduce the size of the abdominal incisions. In this research study, the investigators are looking to see if this investigational procedure is a safe and effective approach to remove rectal cancer of the mid and lower rectum.
Interventions
- PROCEDURE Transanal endoscopic surgery
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 5 participants |
| Start Date | 2011-03 |
| Est. Completion | 2017-05 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01340755
The ClinicalTrials.gov registry entry for NCT01340755 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 5 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Massachusetts General Hospital, which has 2,032 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Transanal endoscopic surgery is the first listed.
NCT01340755 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01340755 about?
NCT01340755 is a clinical study titled "Laparoscopy-Assisted Transanal Endoscopy Rectosigmoid Resection for Rectal Cancer". Transanal Endoscopic Rectosigmoid Resection with Laparoscopic Assistance was developed at Massachusetts General Hospital and performed successfully to remove cancer of the lower rectum. Based on the outcomes, the research doctors believe that this investigational surgery may be as safe and effective...
What is the current status of trial NCT01340755?
This trial is currently completed. It is a NA study. The enrollment target is 5 participants. The study started on 2011-03. Estimated completion is 2017-05.
What interventions are being tested in trial NCT01340755?
The interventions under investigation include: Transanal endoscopic surgery (PROCEDURE).
Who is sponsoring clinical trial NCT01340755?
This trial is sponsored by Massachusetts General Hospital, which has 2,032 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.